ARIAD to Trade on the NASDAQ Global Select Market
CAMBRIDGE, Mass., Jan 03, 2012 (BUSINESS WIRE) -- ARIAD Pharmaceuticals, Inc.
(ARIA) today announced that the Company has been upgraded to trade on the NASDAQ
Global Select Market, the top listing tier for NASDAQ companies with the highest
initial listing standards of any exchange in the world based on financial and
liquidity requirements. Shares of ARIAD common stock will begin trading on the
NASDAQ Global Select Market effective today.
"We are honored to be added to the NASDAQ Global Select Market as we advance our
mission of becoming a leader in the discovery, development and global
commercialization of breakthrough cancer medicines," stated Harvey J. Berger,
M.D., chairman and chief executive officer of ARIAD.
